Clinical Trial Update: The Letrozole Administration During Luteal Phase [Phase 3]

View source ↗

Summary

Phase 3 trial investigating letrozole administration during the luteal phase for a condition related to ovarian hyperstimulation syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: The Affiliated Hospital of Inner Mongolia Medical University | Conditions: Ovarian Hyperstimulation Syndrome | Phase 3 | Status: UNKNOWN